Aprea Therapeutics, Inc. - Common Stock (APRE)

Historical Holders from Q1 2023 to Q3 2025

Symbol
APRE on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
6,887,242
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,618,851
Holdings value
$2,387,744
% of all portfolios
0%
Number of holders
23
Number of buys
6
Number of sells
-8
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common Stock (APRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYTTON LAURENCE W 9.9% $913,662 681,837 LYTTON LAURENCE W 13 Nov 2025
Nantahala Capital Management, LLC 7.3% $720,160 411,520 Nantahala Capital Management, LLC 30 Sep 2024
Stonepine Capital Management, LLC 4.3% -16% $418,978 -$82,213 239,416 -16.4% Stonepine Capital Management, LLC 31 Mar 2025
Sio Capital Management, LLC 1.93% -62.4% $165,529 -$246,540 112,223 -59.8% Sio Capital Management, LLC 30 Sep 2025

Institutional Holders of Aprea Therapeutics, Inc. - Common Stock (APRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1,618,851 $2,387,744 -$296,033 $1.48 23
2025 Q2 1,815,508 $3,072,270 -$77,601 $1.69 23
2025 Q1 1,847,462 $3,768,839 -$165,845 $2.04 25
2024 Q4 2,077,381 $6,829,282 +$211,103 $3.29 26
2024 Q3 2,000,189 $5,500,414 -$431,314 $2.75 21
2024 Q2 2,083,045 $8,477,419 +$1,866,030 $4.07 27
2024 Q1 1,624,394 $10,764,195 +$4,966,764 $6.69 22
2023 Q4 926,780 $4,355,977 +$26,645 $4.7 19
2023 Q3 876,935 $3,660,270 -$19,509 $4.17 19
2023 Q2 881,553 $2,776,892 +$105,033 $3.15 17
2023 Q1 848,237 $3,769,266 +$3,769,266 $4.44 15